THE REVERSIBLE DNA-ALKYLATING ACTIVITY OF DUOCARMYCIN AND ITS ANALOGS

被引:26
作者
ASAI, A [1 ]
NAGAMURA, S [1 ]
SAITO, H [1 ]
TAKAHASHI, I [1 ]
NAKANO, H [1 ]
机构
[1] KYOWA HAKKO KOGYO CO LTD,PHARMACEUT RES LABS,NAGAIZUMI,SHIZUOKA 411,JAPAN
关键词
D O I
10.1093/nar/22.1.88
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Intact drugs with spirocyclopropylhexadienone moieties can be regenerated from the covalent DNA adducts induced by antitumor antibiotics duocarmycin (DUM) A, SA and some DUMA analogues in neutral aqueous solution. We detected the reversible nature of DUMs by determination of the antimicrobial activity and cytotoxicity of DUM-DNA adducts. All of the adducts selectively inhibited the growth of a sensitive strain of Bacillus but not that of the wild type strain, a property of parent DUM and its analogues. Most of the DNA adducts were also cytotoxic to HeLa S3. These results suggested that active drugs can be released from their covalent DNA adducts under these biological assay conditions. Regeneration of intact drugs was quantitatively analyzed by HPLC and the amount of free drug released from DNA adducts revealed that the rate and efficiency of this reversal were dependent on structural variables among the drugs. The differences in rates of reversibility were correlated with the biological activity of DUMs. The effect of pH, temperature and salt concentration on the regeneration of drugs from their DNA adducts suggest a catalytic role of double-helical DNA on the reversal pathway.
引用
收藏
页码:88 / 93
页数:6
相关论文
共 20 条
  • [1] LABILITY OF MONOFUNCTIONAL CISPLATINUM ADDUCTS - ROLE OF DNA DOUBLE HELIX
    ANIN, MF
    GAUCHERON, F
    LENG, M
    [J]. NUCLEIC ACIDS RESEARCH, 1992, 20 (18) : 4825 - 4830
  • [2] ASAI A, 1993, UNPUB
  • [3] SYNTHESIS AND PRELIMINARY EVALUATION OF AGENTS INCORPORATING THE PHARMACOPHORE OF THE DUOCARMYCIN PYRINDAMYCIN ALKYLATION SUBUNIT - IDENTIFICATION OF THE CC-1065 DUOCARMYCIN COMMON PHARMACOPHORE
    BOGER, DL
    ISHIZAKI, T
    ZARRINMAYEH, H
    KITOS, PA
    SUNTORNWAT, O
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1990, 55 (15) : 4499 - 4502
  • [4] ISOLATION AND CHARACTERIZATION OF THE DUOCARMYCIN ADENINE DNA ADDUCT
    BOGER, DL
    ISHIZAKI, T
    ZARRINMAYEH, H
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (17) : 6645 - 6649
  • [5] DUOCARMYCIN PYRINDAMYCIN DNA ALKYLATION PROPERTIES AND IDENTIFICATION, SYNTHESIS, AND EVALUATION OF AGENTS INCORPORATING THE PHARMACOPHORE OF THE DUOCARMYCIN PYRINDAMYCIN ALKYLATION SUBUNIT - IDENTIFICATION OF THE CC-1065-DUOCARMYCIN COMMON PHARMACOPHORE
    BOGER, DL
    ISHIZAKI, T
    ZARRINMAYEH, H
    MUNK, SA
    KITOS, PA
    SUNTORNWAT, O
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (24) : 8961 - 8971
  • [6] DUPLEX OLIGODEOXYRIBONUCLEOTIDES CROSS-LINKED BY MITOMYCIN-C AT A SINGLE SITE - SYNTHESIS, PROPERTIES, AND CROSS-LINK REVERSIBILITY
    BOROWYBOROWSKI, H
    LIPMAN, R
    CHOWDARY, D
    TOMASZ, M
    [J]. BIOCHEMISTRY, 1990, 29 (12) : 2992 - 2999
  • [7] TOPOISOMERASE-TARGETING ANTITUMOR DRUGS
    DARPA, P
    LIU, LF
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 989 (02) : 163 - 177
  • [8] POSSIBLE CATALYTIC ACTIVITY OF DNA IN THE REACTION BETWEEN THE ANTITUMOR DRUG CIS-DIAMMINEDICHLOROPLATINUM(II) AND THE INTERCALATOR N-METHYL-2,7-DIAZAPYRENIUM
    GAUCHERON, F
    MALINGE, JM
    BLACKER, AJ
    LEHN, JM
    LENG, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) : 3516 - 3519
  • [9] DC89-A1, A NEW ANTITUMOR ANTIBIOTIC FROM STREPTOMYCES
    ICHIMURA, M
    MUROI, K
    ASANO, K
    KAWAMOTO, I
    TOMITA, F
    MORIMOTO, M
    NAKANO, H
    [J]. JOURNAL OF ANTIBIOTICS, 1988, 41 (09) : 1285 - 1288
  • [10] DUOCARMYCIN-SA, A NEW ANTITUMOR ANTIBIOTIC FROM STREPTOMYCES SP
    ICHIMURA, M
    OGAWA, T
    TAKAHASHI, K
    KOBAYASHI, E
    KAWAMOTO, I
    YASUZAWA, T
    TAKAHASHI, I
    NAKANO, H
    [J]. JOURNAL OF ANTIBIOTICS, 1990, 43 (08) : 1037 - 1038